NCT04838665View on ClinicalTrials.gov

Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Retinopathy of Prematurity
Interventions
DRUG

0.5% cyclopentolate and 2.5% phenylephrine

Multiple Alternate Instillation of 0.5% cyclopentolate and 2.5% phenylephrine (MAI) dropped every 5 minutes for two doses

DRUG

0.5% tropicamide + 0.5% phenylephrine

Single instillation of 0.5% tropicamide + 0.5% phenylephrine

DRUG

0.5% tropicamide + 0.5% phenylephrine with a cotton wick

Single instillation of 0.5% tropicamide + 0.5% phenylephrine with a cotton wick weighing 0.02 milligrams placed in the inferior fornix for the entire 45 minutes

All Listed Sponsors
lead

University of the Philippines

OTHER

NCT04838665 - Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study | Biotech Hunter | Biotech Hunter